Group 1 - The 2025 China International Service Trade Fair will be held from September 10 to 14, focusing on health and wellness services with the theme "Intelligent Leading Future, Healthy Life" [1] - The health and wellness service section will feature two main display experience areas: "Intelligent Therapy Cloud Matrix" and "National Health Service Matrix" [1] - Major global companies such as Elsevier and GE Healthcare will participate, with a participation rate of 54% from Fortune 500 companies and 53% internationalization rate [1] Group 2 - The Health Priority Zone will showcase innovative projects from local medical institutions, focusing on the integration of medical and elderly care services [2] - A record 48 traditional Chinese medicine institutions will participate, with 27 offline, including leading organizations like Tongrentang and Beijing University of Chinese Medicine [2] - The event will feature immersive experiences such as the "AI Traditional Chinese Medicine Future Clinic" and the debut of a small-scale meridian conditioning robot [2] Group 3 - The Capital International Medical Conference will take place during the trade fair, focusing on the transformation of technological innovation and the development of the pharmaceutical and health industry [3] - The conference will release influential research outcomes, including the "International Influence Report on Clinical Research in Chinese Hospitals" and the "Digital Healthcare Blue Book" [3]

Core Viewpoint - UBS has initiated a "Buy" rating for Guoshengtang with a target price of HKD 48.3, forecasting a compound annual growth rate (CAGR) of 20% for adjusted earnings from 2024 to 2027 [1] Summary by Relevant Categories Company Growth Potential - UBS believes that investors may underestimate Guoshengtang's advantages in attracting doctors, managing policy risks, and serving chronic disease patients from public hospitals [1] - The company's sustainable growth is supported by its expertise in traditional Chinese medicine and value-added services [1] Market Opportunities - There are favorable opportunities for Guoshengtang to enhance doctor coverage and productivity [1] - The company is expanding its self-paid value-added services by leveraging its strengths in the traditional Chinese medicine supply chain, talent, and technology to mitigate policy risks [1]

Group 1 - The Tsinghua University initiative "Liangshan Journey" was launched on August 4, with 43 outstanding teachers and students participating in social practice in Liangshan [1] - Participants visited Haoyisheng Panxi Pharmaceutical to understand its production and operational status, highlighting Liangshan's unique resource advantages and the development of traditional Chinese medicine [5][6] - Haoyisheng's product, Kangfu New Liquid, achieved over 1 billion yuan in annual sales and became the first traditional Chinese medicine to receive certification from Health Canada, showcasing the internationalization of Chinese medicine [8] Group 2 - The company integrates traditional Chinese medicine with modern technology, establishing research platforms and collaborating with multiple universities to drive innovation [6][9] - The digital and intelligent breeding of American cockroaches is showcased, with 22 billion cockroaches being raised in a controlled environment to ensure safety and stability of raw materials [9] - The digitalized production line for Kangfu New Liquid employs smart systems for precise control, enhancing production capacity and quality, contributing to the high-quality development of Liangshan's pharmaceutical industry [9]

Core Points - The forum titled "Integration of Industry, Academia, and Research on Classic Chinese Medicine Formulas" was held in Zhuhai, focusing on the internationalization of traditional Chinese medicine (TCM) [1][3] - The project "Pharmacological Verification and Formulation Optimization of Classic Formulas Huangqi Guizhi Wuwu Decoction and Taohong Siwu Decoction" was officially launched during the forum [1][21] - The event was co-hosted by the Macau University of Science and Technology and Beijing Tongrentang Group, highlighting the collaboration between academia and industry [1][3] Industry Development - The forum aimed to promote the industrialization and academic research of classic TCM formulas, facilitating cross-border exchanges [1][3] - Experts discussed the current state of the TCM industry and the development practices of classic formulas, providing strategies for modernization and internationalization [9][13] - The project received funding of over 12 million Macanese Patacas from the Macao SAR government, indicating strong governmental support for TCM development [21] Collaboration and Future Prospects - The collaboration between Macau University of Science and Technology and Tongrentang Group is seen as a significant step towards modernizing and internationalizing TCM [5][28] - The forum included discussions on the advantages of the Hong Kong-Macao TCM industry and the role of modern technology in TCM research [24][26] - Future efforts will focus on enhancing the international influence of the Tongrentang brand and expanding its market presence globally [7][28]

Group 1 - A group of 21 foreign students from countries such as Portugal, Brazil, and Ireland is studying traditional Chinese medicine in Sanya, Hainan Province [2] - The first Traditional Chinese Medicine Cultural Night Market opened in Shawan City, Xinjiang, featuring medical talents providing services and free health food for citizens [4] - In Nanning, Guangxi, citizens are utilizing traditional therapies like "Sanfu Ties" to enhance their resistance against illnesses during the summer [8] Group 2 - The National Administration of Traditional Chinese Medicine held a press conference discussing health preservation methods through traditional Chinese medicine during the summer [8] - Experts emphasize the importance of preventing heatstroke and sunburn during high temperatures, recommending avoiding outdoor activities during peak UV hours [9][10] - Dietary recommendations include consuming warm beverages instead of cold drinks and focusing on seasonal fruits and vegetables to maintain digestive health [11][12][13] Group 3 - Exercise recommendations suggest engaging in light activities during cooler parts of the day, such as Tai Chi and Baduanjin, to promote health without overexertion [14][15] - For travelers, it is advised to gradually adapt to local foods and maintain hydration to prevent gastrointestinal issues [17][18]

Core Insights - Guangzhou has been selected as one of the 15 cities for the national demonstration project supported by central financial funding for the inheritance and innovation of traditional Chinese medicine (TCM) [1] - The project aims to promote the inheritance and innovation of TCM techniques, talent cultivation, service models, and management system innovations, creating replicable and promotable experiences [1] Group 1: Project Objectives - The project is jointly promoted by the Ministry of Finance and the National Administration of Traditional Chinese Medicine [1] - It aims to establish a national-level demonstration benchmark for TCM development [1] Group 2: Implementation Strategies - Guangzhou will implement three major projects for the inheritance of Lingnan TCM techniques, three specialized projects for TCM scientific research innovation, and three levels of talent team construction [1] - The city plans to innovate four service models and establish five mechanisms for TCM management system innovation [1] - Five major actions will be taken to build the Yangcheng TCM cultural brand [1] Group 3: Expected Outcomes - The initiative aims to create demonstration benchmarks in six areas: technical inheritance, industrial integration, talent teams, service models, mechanism reform, and cultural dissemination [1] - The goal is to develop a TCM model characterized by outstanding clinical efficacy, efficient scientific research transformation, intelligent service systems, and far-reaching cultural influence [1] - This project is expected to provide a replicable model for the high-quality development of TCM in the Guangdong-Hong Kong-Macao Greater Bay Area [1]

8月9日，2025年中草药囊泡研究与应用全球学术会议在广东省广州市举行。与会专家学者共同分享药用 植物囊泡的高水平研究成果，促进国内外合作，助力中医药传承创新以及现代化、国际化发展。 本次大会由中草药囊泡广东省工程研究中心、广东省中医药学会、广州中医药大学第三附属医院主办， 广州中医药大学第三附属医院医学检验科承办。 清华大学药学院教授、全球细胞外囊泡网络亚太区联络员尹航指出，细胞外囊泡作为一个细胞间通讯的 平台技术，为中医药产业升级提供了一个前所未有的机会。在全球细胞外囊泡蓬勃发展浪潮之下，我们 需要在法规、政策、原料供应等方面进行更多国际合作，力争让中草药细胞外囊泡为中药产业升级和国 际化开辟了新路径，让古老智慧与现代科技跨界融合。 （文章来源：科技日报） 南方医科大学基础医学院教授、广东省中医药学会中草药囊泡研究与应用专业委员会副主任委员樊俊兵 介绍，水果富含很多活性成分，包括维生素、矿物质、抗氧化剂等。果蔬囊泡在口服稳定性和生物相容 性上更有优势，未来在口服药物递送系统、功能性食品开发等领域应用前景广阔。 广州中医药大学第三附属医院医学检验科主任、中草药囊泡广东省工程研究中心主任、广东省中医药学 会中 ...

香港浸会大学校长卫炳江表示，该报告是香港浸会大学在推动中医药标准化、现代化及国际化方面 的重要成果之一，展示了中医药研究的快速发展、跨学科融合特征以及在数字健康和系统医学等方面的 广泛影响力。 此外，在分析涵盖的10年间，61.9%的中医药相关研究属医学领域，33.1%涉及生物化学、遗传学 及分子生物学，28.1%涵盖药理学、毒理学和药剂学，反映中医药研究与多个学科的交错与协同发展趋 势。 新华社香港8月7日电（郭辛）香港浸会大学与爱思唯尔7日合作发表《传承与创新：解码中医药科 学发展轨迹》全球研究分析报告，通过系统化数据反映中医药研究的快速发展、跨学科融合等特征。 报告显示，2014年至2023年间，中医药研究共有来自188个国家及地区参与，累计发表超过20万篇 研究文献。研究数量年复合增长率为10.6%，远高于全球科研3.9%的平均增长率。相关文献总量大幅增 加，几乎达到原来的3倍，反映中医药研究领域蓬勃发展。学术影响力方面，14.2%的中医药文献跻身 全球前10%最常被引用文献。 香港浸会大学副校长（研究及拓展）暨研究院院长吕爱平认为，报告凸显中医药正迈向以系统医学 为核心的现代化阶段，融合生命科学与数 ...

本报记者 李婷 8月7日，漳州片仔癀药业股份有限公司（以下简称"片仔癀"）发布公告称，全资子公司片仔癀投资拟作 为有限合伙人以自有或自筹资金认缴出资人民币2亿元，占高鑫润信基金目标募集规模的比例为20%。 "公司基于大健康产业链上下游考虑，立足现有发展需求，积极寻找新增长点，增强产业协同效应，提 升持续竞争能力，在确保主营业务发展的前提下，拟投资高鑫润信基金。"片仔癀董秘办相关人士对 《证券日报》记者表示。 资料显示，高鑫润信基金主要投资领域为医疗健康领域，包含药品、医疗器械、医疗健康上游供应链及 零部件、食品保健品、消费医疗等大健康相关领域，医疗健康以外的其他领域投资占比不超过基金认缴 出资规模的10%。 事实上，除了此次参与高鑫润信基金，片仔癀在产业投资领域动作频频。此前，公司就曾尝试通过投资 并购来拓展业务版图。 中国医药健康发展促进专家委员会主任委员申勇对《证券日报》记者表示："片仔癀的挑战主要包括对 核心单品依赖较大、多元化发展成果不够显著、在渠道品牌建设方面依然存在区域不平衡等。通过布局 产业基金，片仔癀既能够实现产业链上下游延伸挖掘，同时有望在医院外市场、大健康、新药等领域开 拓新项目，挖掘新增 ...

Core Viewpoint - Pianzaihuang Pharmaceutical is actively investing in the health industry by participating in the establishment of the Gao Xin Run Xin Fund, aiming to enhance its competitive edge and explore new growth opportunities within the health industry chain [1] Group 1: Investment Activities - Pianzaihuang plans to invest 200 million RMB in the Gao Xin Run Xin Fund, which represents 20% of the fund's target fundraising scale [1] - The Gao Xin Run Xin Fund is part of the "Yuan Shan Plan," a major industrial project initiated in April 2024 in Zhangzhou, focusing on creating a comprehensive ecosystem for traditional Chinese medicine [1] - The Zhangzhou government aims to establish a total of 5 billion RMB in health industry funds, with the Gao Xin Run Xin Fund being the third fund launched under this initiative [1] Group 2: Previous Fund Investments - In September 2024, Pianzaihuang announced a 200 million RMB investment in the Zhangzhou Yuan Shan Health Industry Investment Fund, holding a 40% stake in the first phase of the fund [2] - The Yuan Shan Fund has already achieved significant profits, with a reported investment return rate of 376% from acquiring a 5.02% stake in Guangsheng Tang, which has appreciated from 196 million RMB to a current market value of 932 million RMB [2] - In March 2025, Pianzaihuang also invested 200 million RMB in the Zhaoying Huikang Fund, which is managed by Zhaoshang Zhiyuan Capital and has a planned scale of 1 billion RMB [2] Group 3: Financial Performance - Pianzaihuang reported a revenue of 10.788 billion RMB in 2024, reflecting a year-on-year growth of 7.25%, and a net profit of 2.977 billion RMB, with a growth of 6.42% [2] - This marks the 15th consecutive year of revenue and net profit growth for Pianzaihuang, demonstrating its strong market competitiveness and resilience amid a slowing growth rate in the traditional Chinese medicine industry [2]